Octant

Octant

Private
Emeryville, CaliforniaHealthcare & Life Scienceshttps://www.octant.bio

Last Round

Grant

Jun 11, 2025

Total Funding Raised

$119.9M

Company Overview

Octant Bio is a biotechnology company that develops synthetic technology to enhance health and address diseases through advanced synthetic biology and machine learning techniques.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

drug discovery platformAI drug discoverysmall molecule drugssynthetic biologysynbiogenerative drug discoveryplatform biotechhigh-throughput screeningpolypharmacologyprecision medicinedeep mutational scanningDMSgenerative chemistrygenerative biologymultiplexed assaysoncology therapeuticsrare disease therapeuticsprotein misfolding diseases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Octant Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Octant Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJun 11, 2025
Series BApr 21, 2022
Series AMay 20, 2020

Key People

Founding team and executive leadership

Sri Kosuri

Co-Founder And CEO

Founding Team

Octant Investors

Notable investors and investment history

InvestorRounds
Andreessen HorowitzSeries A
SV AngelSeries A
Allen & CompanySeries B, Series A
Gates Family FoundationGrant
Catalio Capital ManagementSeries B
Andreessen Horowitz Bio + HealthSeries B, Series A
8VCSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2025

    Launched Latitude, a platform for exploring local experiences.

  • Apr 4, 2025

    Cofounder to speak at RBC 2025 Ophthalmology Conference.

Octant Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Octant Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Octant's valuation, stock price, and market status.

Firmographic Details

HeadquartersEmeryville, California
Employee Range70
Year Founded2017
Last FundingJun 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.